ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,126Medicare Part D Prescriptions Filled, Including Refills

Rank: 210 out of 633

$357K Total Retail Price of All Prescriptions

Rank: 189 out of 633

258 Patients Receiving at Least One Drug in Part D
79% Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nebraska
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

10% of this provider’s 258 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
HYDROCODONE-ACETAMINOPHEN 232 70 21 S3 1 8
LEVOTHYROXINE SODIUM 223 184 37 2 1
TRAMADOL HCL 200 82 36 3 15
OMEPRAZOLE 189 130 35 4 2
SIMVASTATIN 182 177* 30 5 3
PRAVASTATIN SODIUM 160 142 36 6 21
AMLODIPINE BESYLATE 140 135* 26 7 4
GABAPENTIN 127 72 26 8 16
TAMSULOSIN HCL 123 107 18 9 24
SERTRALINE HCL 120 <11 <11 10 19
BENAZEPRIL HCL 120 94 25 10 50
METOPROLOL SUCCINATE 119 114* 22 12 13
MELOXICAM 118 101 35 13 23
CYCLOBENZAPRINE HCL 111 47 21 R 14 80
ZOLPIDEM TARTRATE 104 70 18 15 26
ATORVASTATIN CALCIUM 101 78 18 16 9
GLIMEPIRIDE 98 98 17 17 38
TRIAMTERENE-HCTZ 93 79 17 18 49
LISINOPRIL 90 85* 21 19 5
METFORMIN HCL 85 80* 20 20 10
ATENOLOL 83 78* 13 21 22
CITALOPRAM HBR 82 77* 14 22 20
LOSARTAN POTASSIUM 78 73* 12 23 17
FLUTICASONE PROPIONATE 77 52 24 24 39
CLONAZEPAM 75 32 11 B 25 54
ALENDRONATE SODIUM 74 74 11 26 35
RANITIDINE HCL 73 46 15 27 45
FENOFIBRATE* 72 67* 13 28 60
MONTELUKAST SODIUM 71 66* 11 29 59
JANUVIA 67 51 11 30 97
CLOPIDOGREL 65 <11 <11 31 30
WARFARIN SODIUM 64 47 11 32 7
METOPROLOL TARTRATE 63 58* 12 33 12
ALPRAZOLAM 63 51 12 B 33 32
NAMENDA 63 <11 <11 33 34
BACLOFEN 54 27 14 36 136
ACETAMINOPHEN-CODEINE 52 <11 <11 S3 37 165
CELEBREX 52 <11 <11 37 61
FUROSEMIDE 52 47* 21 37 6
PROPRANOLOL HCL 51 <11 <11 40 106
LEVOFLOXACIN 51 32 29 40 83
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 13, 2015.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.